Key result
Interleukin-10 (150 ng/ml) inhibited monocyte adhesion to endothelial cells by 35% and to carotid arteries by 40-50%, while decreasing MMP-9 activity and increasing TIMP-1 levels.
IL-10 demonstrates anti-inflammatory properties by inhibiting monocyte-endothelial cell interactions and modulating MMP-9/TIMP-1 expression, suggesting a potential role in preventing arteriosclerosis and restenosis.
No takes yet. Share an insight, caveat, or question.
IL-10 may inhibit monocyte-endothelial interactions in vitro; leaves open its role in arteriosclerosis and restenosis.
El Mostafa Mtairag (2001) studied Arteriosclerosis and restenosis. Interleukin-10 (IL-10) was evaluated on Monocyte adhesion to endothelial cells and carotid arteries. Interleukin-10 (150 ng/ml) inhibited monocyte adhesion to endothelial cells by 35% and to carotid arteries by 40-50%, while decreasing MMP-9 activity and increasing TIMP-1 levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: